After exhausting standard treatment options for Grade 4 glioblastoma in Canada, Ronald and his wife Freya traveled to Germany to pursue personalized cancer treatment. In this interview, they share their experience navigating international care, the impact on Ronald’s quality of life, and the results that renewed hope for their family. Learn more at https://bookinghealth.com/#send-requestLangenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.